Search | IOVS | ARVO Journals

Showing 1 – 20 of 53

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Travoprost intraocular implant (iDose® TR) delivers therapeutically relevant and durable aqueous humor drug concentrations at 24 months and demonstrates safety of repeat implant administration

Gabriella Szekely; L. Jay Katz; Lilit A. Voskanyan; Inhou Chu; Jennifer Seal; Jia-Ying Yang; Long V. Doan; Kerry G. Stephens; Teresa P. Mena; Debbie S. Capel; Samuel Placinta; Rachel J. Wilson; Danielle N. Armijo; Dale Usner; David Applegate; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1913.

ARVO Annual Meeting Abstract June 2024

Travoprost intraocular implant demonstrated an excellent systemic safety profile with no measurable systemic drug levels

L. Jay Katz; Gabriella Szekely; Jennifer Seal; Long V. Doan; Kerry G. Stephens; Teresa P. Mena; Debbie S. Capel; Sam Placinta; Rachel J. Wilson; Danielle N. Armijo; Dale Usner; David Applegate; Angela C Kothe; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1912.

ARVO Annual Meeting Abstract June 2024

Clinical evaluation of new canalicular insert for treatment of dry eye disease

William Tran; Kenneth Curry; Lilit A. Voskanyan; Kerry G. Stephens; Dale Usner; Angela C Kothe; L. Jay Katz; Jeffrey Ray Holland; Reesha Faye Alvarado; Dari Parizadeh; Kun Zheng; Carol Lehto; Katelyn Arden; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2986.

ARVO Annual Meeting Abstract June 2023

Riboflavin Ophthalmic Solution activated in situ with a novel scanning laser-based bioactivation system, the NXL UV-A device, demonstrates safety of corneal cross-linking for the treatment of keratoconus

Valerie Smith; Sebastian B. Heersink; Peter Hersh; Kenneth A. Beckman; George O. Waring; Marco E. Armijo; Mitchell J. Gray; Kimi Luc; Alex Yildizyan; David B Usher; Kerry G. Stephens; Angela C. Kothe; Dale Usner; Terence Koritz; L. Jay Katz; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1675.

ARVO Annual Meeting Abstract June 2023

Travoprost intraocular implant (iDoseTR ® ) delivers therapeutically relevant and durable aqueous humor drug concentration levels at 12 months and demonstrates safety of implant repeat dosing

Gabriella Szekely; L. Jay Katz; Lilit A. Voskanyan; Iona D. Raymond; Jia-Ying Yang; Long V Doan; Kerry G. Stephens; Teresa P. Mena; Debbie S. Capel; Samuel Placinta; Rachel J. Wilson; Danielle N. Armijo; Christian L. Davis; David Applegate; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4301.

ARVO Annual Meeting Abstract June 2023

Results of the prospective, randomized, controlled, multicenter phase 3 trials of the travoprost intraocular implant versus topical timolol

L. Jay Katz; Steven R. Sarkisian; Lilit A. Voskanyan; Robert T. Ang; Mark J. Gallardo; John P. Berdahl; Sebastian B. Heersink; George R. Reiss; Long V Doan; Kerry G. Stephens; Robert J. Sanchez; David Applegate; Dale Usner; Kenneth M. Curry; Dave S. Haffner; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4296.

ARVO Annual Meeting Abstract June 2022

Changes in Glaucoma Management Following Diurnal Home Tonometry

Nicholas O'Connor; Lauren E Hock; Aakriti Garg Garg Shukla; Natasha N Kolomeyer; Reza Razeghinejad; L. Jay Katz; Jonathan S Myers; Daniel Lee

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):159 – A0352.

ARVO Annual Meeting Abstract June 2022

Successful reduction in topical medication burden in glaucoma patients at 3 years with iDose intracameral therapy versus timolol

L. Jay Katz; Long Doan; David Applegate; Christian Davis; Kerry Stephens; Tomas Navratil

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3696 – A0381.

ARVO Annual Meeting Abstract June 2021

Sociodemographic and Economic Factors in Outcomes of Tube Shunts for Neovascular Glaucoma

Amirmohsen Arbabi; Wesam Shamseldin Shalaby; Jonathan S. Myers; Marlene R. Moster; Reza Razeghinejad; L. Jay katz; Aakriti Garg Shukla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3416.

ARVO Annual Meeting Abstract June 2021

Evaluation of the Hypertensive Phase after Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma

Sunidhi Ramesh; Wesam Shamseldin Shalaby; Jonathan S. Myers; L. Jay katz; Marlene R. Moster; Reza Razeghinejad; Aakriti Garg Shukla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3425.

ARVO Annual Meeting Abstract June 2021

The Effect of Phacoemulsification on the Functioning Tube Shunts in Open Angle Glaucoma

Wesam Shamseldin Shalaby; Sophia Lam; Allen Ganjei; Sonali Patel; Aakriti Garg Shukla; Natasha Nayak Kolomeyer; daniel lee; L. Jay katz; Marlene R. Moster; Jonathan S. Myers; Reza Razeghinejad

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3440.

ARVO Annual Meeting Abstract July 2019

Risk of auto accidents in patients with moderate-stage glaucoma

Sheryl S Wizov; Eric Shiuey; Carina Sanvicente; Benjamin E. Leiby; Judie Tran; Michael Waisbourd; Jonathan S. Myers; L Jay Katz; Marlene R Moster; George L Spaeth

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3628.

ARVO Annual Meeting Abstract July 2019

The Efficacy and Safety Profile of Netarsudil 0.02% in Glaucoma Treatment: Real-World Outcomes

Melih Ustaoglu; Eric Shiuey; Carina Sanvicente; Reza Razeghinejad; L. Jay Katz; Jonathan S Myers; Daniel Lee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2393.

ARVO Annual Meeting Abstract July 2019

Beliefs and Attitudes of Ophthalmologists Regarding Selective Laser Trabeculoplasty as First Line Therapy for Glaucoma

Lucas Bonafede; Judie Tran; Lisa A Hark; Carina Sanvicente; Qiang Zhang; Rose Costello; L. Jay Katz

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2829.

ARVO Annual Meeting Abstract July 2018

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Interphysician Agreement for Screening Images

Natasha Nayak Kolomeyer; Lisa A Hark; L. Jay Katz; Jonathan S. Myers; Daniel Lee; M. Reza Razeghinejad; Stela Leite; Kamran Rahmatnejad; Tingting Zhan; Benjamin Leiby; Sarah Hegarty; Paul P Lee

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2737.

ARVO Annual Meeting Abstract July 2018

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Adherence to Community Eye Exam Appointments

Lisa A Hark; L. Jay Katz; Jonathan S. Myers; Julia A Haller

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6154.

ARVO Annual Meeting Abstract June 2017

Reproducibility of Minimum Rim Width and Retinal Nerve Fiber Layer Thickness Measurements using the Anatomic Positioning System in Patients with Glaucoma and Normal Controls

Lalita Gupta; Priyanka Gogte; Safa Siraj; Scott S Fudemberg; Anand V Mantravadi; Lisa A Hark; L Jay Katz; Michael Waisbourd

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1322.

ARVO Annual Meeting Abstract June 2017

A Longitudinal Analysis of the Impact of Glaucoma on Performance in Daily Life.

James Murphy; Karishma Kodia; Michael Waisbourd; Remy Serge Manzi Muhire; Ting Ting Zhan; Kamran Rahmatnejad; Shuai-Chun Lin; Sheryl S Wizov; Lisa A Hark; Jonathan S Myers; Scott S Fudemberg; Anand V Mantravadi; L Jay Katz; Marlene Moster; Michael Pro; George L. Spaeth

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1345.

ARVO Annual Meeting Abstract June 2017

Measuring Contrast Sensitivity with SPARCS in Specific Areas of Vision – A Meaningful Way to Assess Quality of Life and Ability to Perform Daily Activities in Glaucoma Patients

Karishma Kodia; Michael Waisbourd; Priyanka Gogte; Hamoon Eshraghi; Daniel Lee; Remy Serge Manzi Muhire; Sheryl S Wizov; Jonathan S Myers; Scott S Fudemberg; Anand V Mantravadi; L Jay Katz; Marlene Moster; Michael Pro; George L. Spaeth; Lisa A Hark

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3296.

ARVO Annual Meeting Abstract June 2017

Prevalence of glaucoma and visual field changes in professional wind versus non-wind instrument players in the Philadelphia Orchestra

Shuai-Chun Lin; Cindy Xin Zheng; Michael Waisbourd; Jeanne Molineaux; Lichuan Zeng; Ting Ting Zhan; Kamran Rahmatnejad; ARTHUR RESENDE; Anand Mantravadi; Lisa A Hark; Joseph I Markoff; George L. Spaeth; L. Jay Katz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3708.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Travoprost intraocular implant (iDose® TR) delivers therapeutically relevant and durable aqueous humor drug concentrations at 24 months and demonstrates safety of repeat implant administration

Travoprost intraocular implant demonstrated an excellent systemic safety profile with no measurable systemic drug levels

Clinical evaluation of new canalicular insert for treatment of dry eye disease

Riboflavin Ophthalmic Solution activated in situ with a novel scanning laser-based bioactivation system, the NXL UV-A device, demonstrates safety of corneal cross-linking for the treatment of keratoconus

Travoprost intraocular implant (iDoseTR ® ) delivers therapeutically relevant and durable aqueous humor drug concentration levels at 12 months and demonstrates safety of implant repeat dosing

Results of the prospective, randomized, controlled, multicenter phase 3 trials of the travoprost intraocular implant versus topical timolol

Changes in Glaucoma Management Following Diurnal Home Tonometry

Successful reduction in topical medication burden in glaucoma patients at 3 years with iDose intracameral therapy versus timolol

Sociodemographic and Economic Factors in Outcomes of Tube Shunts for Neovascular Glaucoma

Evaluation of the Hypertensive Phase after Ahmed Glaucoma Valve Implantation in Neovascular Glaucoma

The Effect of Phacoemulsification on the Functioning Tube Shunts in Open Angle Glaucoma

Risk of auto accidents in patients with moderate-stage glaucoma

The Efficacy and Safety Profile of Netarsudil 0.02% in Glaucoma Treatment: Real-World Outcomes

Beliefs and Attitudes of Ophthalmologists Regarding Selective Laser Trabeculoplasty as First Line Therapy for Glaucoma

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Interphysician Agreement for Screening Images

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Adherence to Community Eye Exam Appointments

Reproducibility of Minimum Rim Width and Retinal Nerve Fiber Layer Thickness Measurements using the Anatomic Positioning System in Patients with Glaucoma and Normal Controls

A Longitudinal Analysis of the Impact of Glaucoma on Performance in Daily Life.

Measuring Contrast Sensitivity with SPARCS in Specific Areas of Vision – A Meaningful Way to Assess Quality of Life and Ability to Perform Daily Activities in Glaucoma Patients

Prevalence of glaucoma and visual field changes in professional wind versus non-wind instrument players in the Philadelphia Orchestra

To View More...

You must be signed into an individual account to use this feature.